Hite R Duncan, Seeds Michael C, Safta Anca M, Jacinto Randolph B, Gyves Julianna I, Bass David A, Waite B Moseley
Section of Pulmonary Medicine, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157-1054, USA.
Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L618-24. doi: 10.1152/ajplung.00274.2004. Epub 2004 Oct 29.
Pulmonary surfactant's complex mixture of phospholipids and proteins reduces the work of breathing by lowering alveolar surface tension during respiration. One mechanism of surfactant damage appears to be the hydrolysis of phospholipid by phospholipases activated in the inflamed lung. Humans have several candidate secretory phospholipase A(2) (sPLA(2)) enzymes in lung cells and infiltrating leukocytes that could damage extracellular surfactant. We considered two mechanisms of surfactant disruption by five human sPLA(2)s, including generation of lysophospholipids and the depletion of specific phospholipids. All five sPLA(2)s studied ultimately caused surfactant dysfunction. Each enzyme exhibited a different pattern of hydrolysis of surfactant phospholipids. Phosphatidylcholine, the major phospholipid in surfactant and the greatest potential source for generation of lysophospholipids, was susceptible to hydrolysis by group IB, group V, and group X sPLA(2)s, but not group IIA or IID. Group IIA hydrolyzed both phosphatidylethanolamine and phosphatidylglycerol, whereas group IID was active against only phosphatidylglycerol. Thus, with groups IB and X, the generation of lysophospholipids corresponded with surfactant dysfunction. However, hydrolysis of and depletion of phosphatidylglycerol had a greater correlation with surfactant dysfunction for groups IIA and IID. Surfactant dysfunction caused by group V sPLA(2) is less clear and may be the combined result of both mechanisms.
肺表面活性物质由磷脂和蛋白质组成的复杂混合物,在呼吸过程中通过降低肺泡表面张力来减少呼吸功。表面活性物质受损的一种机制似乎是炎症肺部激活的磷脂酶对磷脂的水解作用。人类肺细胞和浸润白细胞中有几种可能的分泌型磷脂酶A2(sPLA2)酶,它们可能会破坏细胞外表面活性物质。我们研究了5种人sPLA2破坏表面活性物质的两种机制,包括溶血磷脂的生成和特定磷脂的消耗。所研究的所有5种sPLA2最终都导致了表面活性物质功能障碍。每种酶对表面活性物质磷脂的水解模式都不同。磷脂酰胆碱是表面活性物质中的主要磷脂,也是溶血磷脂生成的最大潜在来源,易受IB组、V组和X组sPLA2的水解作用,但不受IIA组或IID组的影响。IIA组水解磷脂酰乙醇胺和磷脂酰甘油,而IID组仅对磷脂酰甘油有活性。因此,对于IB组和X组,溶血磷脂的生成与表面活性物质功能障碍相对应。然而,对于IIA组和IID组,磷脂酰甘油的水解和消耗与表面活性物质功能障碍的相关性更大。V组sPLA2引起的表面活性物质功能障碍不太明确,可能是两种机制共同作用的结果。